Skip to content

R&D at other companies

Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$62.9M-14.4%
iRadimed logo
iRadimedIRMD
$956K+53.2%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
$49.92M-29.6%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$15.8M-3.1%
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
$1.22M-42.1%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
$14.18M+14.4%

Other financials

Income statement

See full
Revenue$8.0M+11.1%
Gross profit$371.0K-8.2%
Operating income-$13.9M-18.8%
Net income-$14.3M-26.7%
EPS (diluted)-$0.31-19.2%

Balance sheet

See full
Cash & equivalents$14.1M-26.8%
Total debt$23.8M+301%
Total equity$20.4M-68.9%
Total assets$62.4M-27.0%

Cash flow

See full
Operating cash flow-$15.1M-66.1%
CapEx$394.0K+23.5%
Free cash flow-$15.5M-64.7%

Valuation

See full
Market cap$86.19M-43.8%
Enterprise value$95.86M-31.7%
P/S2.5×-2.6×

Profitability

See full
Operating margin-144.2%-12.7pp
Net margin-145.8%-5.0pp
FCF margin-110.5%-14.9pp

Returns & leverage

See full
Return on equity-116.7%-620pp
Debt / equity1.2×+1.1×
Current ratio2.6×-2.0×

Where this comes from

Reported directly by Rapid Micro Biosystems in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Rapid Micro Biosystems’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rapid Micro Biosystems's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rapid Micro Biosystems's R&D?
Rapid Micro Biosystems (RPID) reported R&D of $3.36M in Q1 2026.
How has Rapid Micro Biosystems's R&D changed year-over-year?
Rapid Micro Biosystems's R&D decreased by 7.3% year-over-year, from $3.62M to $3.36M.
What is the long-term trend for Rapid Micro Biosystems's R&D?
Over 4 years (2021 to 2025), Rapid Micro Biosystems's R&D has grown at a 8.6% compound annual growth rate (CAGR), from $9.78M to $13.6M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.